By inhibiting NLRP3 inflammasome activation, irisin effectively restrained the expression of GSDMD-N and IL-1β, thereby mitigating the detrimental effects of pressure overload on the heart such as myocardial inflammation, fibrosis, and hypertrophy (148). The gene discussed is NLRP3; the disease is myocarditis.